T-CELL DYSREGULATION IN PATIENTS WITH HYPERPROLACTINEMIA - EFFECT OF BROMOCRIPTINE TREATMENT

被引：63
作者：
VIDALLER, A
LLORENTE, L
LARREA, F
MENDEZ, JP
ALCOCERVARELA, J
ALARCONSEGOVIA, D
机构：
[1] INST NACL NUTR SALVADOR ZUBIRAN,DEPT IMMUNOL & RHEUMATOL,MEXICO CITY 14000,DF,MEXICO
[2] INST NACL NUTR SALVADOR ZUBIRAN,DEPT REPROD BIOL,MEXICO CITY 14000,DF,MEXICO
来源：
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1986年 / 38卷 / 03期
关键词：
D O I：
10.1016/0090-1229(86)90243-6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：337 / 343
页数：7
相关论文
共 50 条
[41]   DOPAMINE AGONISTS IN THE TREATMENT OF HYPERPROLACTINEMIA - COMPARISON BETWEEN BROMOCRIPTINE AND LISURIDE [J].
STRACKE, H ;
HEINLEIN, W ;
HOROWSKI, R ;
SCHATZ, H .
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-2 (12) :1834-1836
[42]   HYPERPROLACTINEMIA IN INFERTILE THAI WOMEN, ITS INCIDENCE AND TREATMENT WITH BROMOCRIPTINE [J].
SRIVANNABOON, S ;
ONGSANGKUL, T ;
TUNGSUBUTARA, V ;
MAKEMAHARN, O ;
KARAVAGUL, C .
JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1985, 68 (12) :638-642
[43]   Infliximab treatment improves PML in sarcoidosis patients with T cell dysregulation [J].
Rosenkranz, S. C. ;
Thom, V. ;
Willing, A. ;
Kolster, M. ;
Tolosa, E. ;
Friese, M. A. .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 :859-859
[44]   THE EFFECTS OF PROLONGED BROMOCRIPTINE ADMINISTRATION ON GLYCEMIC CONTROL IN PATIENTS WITH HYPERPROLACTINEMIA [J].
Danciulescu Miulescu, Rucsandra ;
Trifanescu, Raluca ;
Carsote, Mara ;
Paun, Sorin ;
Culman, Mirela ;
Sfetea, Roxana Corina ;
Margina, Denisa ;
Poiana, Catalina .
INTERDIAB 2016: DIABETES MELLITUS AS CARDIOVASCULAR DISEASE, 2016, :195-200
[45]   Angioimmunoblastic T-cell lymphoma: the effect of initial treatment and microvascular density in 31 patients [J].
Shu Zhao ;
Liangyu Zhang ;
Minghui Zhang ;
Guodong Yao ;
Xiaosan Zhang ;
Wenhui Zhao ;
Wei Ren ;
Jingxuan Wang ;
Qingyuan Zhang .
Medical Oncology, 2012, 29 :2311-2316
[46]   Angioimmunoblastic T-cell lymphoma: the effect of initial treatment and microvascular density in 31 patients [J].
Zhao, Shu ;
Zhang, Liangyu ;
Zhang, Minghui ;
Yao, Guodong ;
Zhang, Xiaosan ;
Zhao, Wenhui ;
Ren, Wei ;
Wang, Jingxuan ;
Zhang, Qingyuan .
MEDICAL ONCOLOGY, 2012, 29 (04) :2311-2316
[47]   Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia -: A case report [J].
Bliesener, N ;
Yokusoglu, H ;
Quednow, BB ;
Kingmüller, D ;
Kühn, KU .
PHARMACOPSYCHIATRY, 2004, 37 (04) :189-191
[48]   TREATMENT OF TYPE-III HYPERLIPOPROTEINEMIA WITH BROMOCRIPTINE IN A PREMENOPAUSAL WOMAN WITH HYPERPROLACTINEMIA [J].
STOCK, JL ;
HIGANO, N ;
ROBINSON, RW ;
HAAS, R .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (04) :761-762
[49]   DELAYED PUBERTY AND HYPOPLASTIC UTERUS ASSOCIATED WITH HYPERPROLACTINEMIA - SUCCESSFUL TREATMENT WITH BROMOCRIPTINE [J].
KAULI, R ;
SCHOENFELD, A ;
OVADIA, Y ;
MATH, S ;
ASSA, S ;
LARON, Z .
HORMONE RESEARCH, 1985, 22 (1-2) :68-73
[50]   LONG-ACTING ORAL BROMOCRIPTINE (PARLODEL SRO) IN THE TREATMENT OF HYPERPROLACTINEMIA [J].
WEINGRILL, CO ;
MUSSIO, W ;
MORAES, CRS ;
PORTES, E ;
CASTRO, RC ;
LENGYEL, AMJ .
FERTILITY AND STERILITY, 1992, 57 (02) :331-335
12345